Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study
Authors:
- Molecular Diagnostics of Sepsis study groupMGMolecular Diagnostics of Sepsis study group
- Karsten BeckerKarsten Becker
- 9 January 2015
- journal article
- research article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 204 (5) , 585-592
Abstract
Multiplex PCR (mPCR) directly from blood has been suggested as a promising method for rapid identification of pathogens causing sepsis. This study aimed to investigate whether mPCR has any impact on antimicrobial treatment. Hematological patients with febrile neutropenia were randomized into two groups. In the study group, mPCR was performed as an addition to standard diagnostics, and PCR finding was immediately communicated to the clinicians, thus being available for decision making. In the control group, clinicians were not aware of PCR result. PCR samples were collected simultaneously with clinically indicated blood culture specimens from peripheral vein and/or central venous catheter at fever onset and once again if fever persisted up to 72 h. Overall, 74 patients of the study group and 76 patients of the control group were enrolled and 253 samples collected. Therapy was changed to targeted antimicrobial therapy (AMT) in 12 patients (16.2 %) in the study group and in 12 patients (15.8 %) in the control group. For patients with changes, the median time to change to the targeted AMT was 21.4 h in the study group and 47.5 h in the control group (p = 0.018). In the study group, 57.1 % (8/14) of changes to targeted AMT was due to PCR finding. PCR led to AMT change in 9.5 % (7/74) of study group patients, i.e., in 33.3 % (7/21) of patients who had positive PCR finding. There were no significant differences in patient outcomes (secondary endpoints). In conclusion, PCR method accelerates change to the targeted AMT in febrile neutropenic patients.Keywords
This publication has 29 references indexed in Scilit:
- Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsisWiener klinische Wochenschrift, 2012
- PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRSLangenbeck's Archives of Surgery, 2011
- Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical viewIntensive Care Medicine, 2011
- Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patientsInternational Journal of Infectious Diseases, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and OncologyAnnals of Oncology, 2010
- Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsisJournal of Infection, 2010
- A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsisIntensive Care Medicine, 2009
- Detection of microbial DNAemia: does it matter for sepsis management?Intensive Care Medicine, 2009
- A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samplesMedical Microbiology and Immunology, 2007